Search Results for keywords:"substance use disorders"

The National Institute on Drug Abuse has announced closed meetings scheduled for February 21 and February 24, 2025, according to the Federal Advisory Committee Act. These meetings are closed to the public to protect confidential information discussed during grant application reviews. The February 21 meeting will focus on the relationship between sleep and substance use disorders, while the February 24 meeting will examine the link between autophagy, HIV, and substance use disorders. Both meetings will be held virtually, and specific contact information is provided for those interested.

The National Institute on Drug Abuse is holding two closed meetings to discuss grant applications for special emphasis panels. The first meeting on February 26, 2021, will focus on device-based treatments for substance use disorders. The second meeting, scheduled for March 3, 2021, will review research on HIV/AIDS through computational neuroscience. These meetings are closed to the public to protect confidential information and personal privacy.

The National Institute on Drug Abuse announced several closed virtual meetings to review and evaluate grant applications. These meetings are part of its efforts related to the HEAL Initiative focused on ending the overdose crisis, research on the impact of structural racism on substance use, and developing digital therapies for substance use disorders. Due to the sensitivity of the information discussed, such as trade secrets and personal information, these meetings are not open to the public. The meetings are scheduled for January 23-24, February 3, and February 5, 2025.

The National Institute on Drug Abuse, part of the National Institutes of Health, announced several closed meetings to discuss and evaluate grant applications. These meetings, scheduled for February 2021, will be held virtually due to the confidential nature of the discussions, which may involve trade secrets and personal information. Committees will review applications related to HIV prevention, gene editing in marmosets, validating genes involved in substance use disorders, and NIDA Centers Review. As these are closed meetings, the public will not be able to attend.